A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients - sprookjes - yvandenbroek - TriplyDB

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

http://www.wikidata.org/entity/Q33845632

about

OCT1 pharmacogenetics in pain management: is a clinical application within reach?The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine.

P2860

Q43075700-C6AD5D04-B387-4C5E-87E5-6C1896BA17B2 Q47693272-4580D97F-D5B1-4DAD-8982-FE6B734A53C0

P2860

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

http://www.wikidata.org/entity/Q33845632

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

@ast

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

@en

type

label

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

@ast

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

@en

prefLabel

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

@ast

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

@en

P1433

Q33845632-40F587F5-CF15-47F8-8AC2-C8A7728960B2

P1476

Q33845632-2681A185-6672-4212-8B7F-30FE38C28870

P2093

Q33845632-2034ACAC-79D3-468D-AC42-B4FE237D50C7

Q33845632-2AB686D0-EAB4-4E18-901B-1D7F958D70B9

Q33845632-5197FC4F-CE27-4BA2-B24A-09CEC3CF408D

Q33845632-568B12BE-F91C-400C-A370-BD9FA73FC073

Q33845632-BE50F58F-C70F-4D0D-A5DB-294419B39CF0

Q33845632-D23EC7D3-149A-4FB7-BDCF-5CD4DB87D863

Q33845632-EE1E1948-F729-404A-AF1A-79985D860BE5

P2860

Q33845632-007A07A3-353F-4671-8919-200A8E50BD9C

Q33845632-03108657-DA3A-4B4E-82B3-76267D05745C

Q33845632-1589831D-CD56-4858-9960-9DF1915D6C3D

Q33845632-1BFA3C19-3F0A-46F2-B28D-0CAEDDE83517

Q33845632-29D0E5ED-7B48-4199-A51E-96A585D33691

Q33845632-2B62DF81-0007-42E4-B08E-17192CDFEA1F

Q33845632-30D3779C-9B4B-4DFD-A756-B86438CB858B

Q33845632-311E2311-1B1E-4340-867B-26FB30EA069E

Q33845632-32C1B26A-B201-49E2-8706-CCA47242FDD1

Q33845632-34BDE16D-62A9-4A2A-9FD3-D829173CEDFA

P2888

Q33845632-DED29019-E44C-4A71-9D42-F0C63E5E3EC7

P304

Q33845632-31892826-0626-4F6A-93C8-9548ECE03C43

P31

Q33845632-92A7A108-3F74-4288-B1A8-5B48C0760DFE

P356

Q33845632-B45D5423-FA05-4BE0-BCB4-11496AD7170A

P433

Q33845632-3A18BFBB-0419-4CB8-A6CE-04F5E530F2E1

P478

Q33845632-895C3A1B-DA60-4D2D-B81C-A6E500F68ECE

P50

Q33845632-74202D9D-52D3-4DC4-B159-7E91DFCB5142

P577

Q33845632-70201099-F14E-4F30-B9C1-BBDCD17993E1

P6179

Q33845632-8EB06DB2-5ACA-494F-BF19-24BFEFF2433C

P698

Q33845632-F062D41B-897B-4497-A29F-064AC69F5277

P921

Q33845632-6D8A4F41-DB37-4569-A23D-04B6E759CF46

P932

Q33845632-AE4638E4-C698-4F6B-8A5A-2ECBEE6E8D98

P356

S40262-016-0471-7

P1433

Clinical Pharmacokinetics

P1476

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

@en

P2093

Astrid W Oosten

http://www.w3.org/2001/XMLSchema#string

Carin C D van der Rijt

http://www.w3.org/2001/XMLSchema#string

Maja Matic

http://www.w3.org/2001/XMLSchema#string

Peter de Bruijn

http://www.w3.org/2001/XMLSchema#string

Ron H J Mathijssen

http://www.w3.org/2001/XMLSchema#string

Ron H N van Schaik

http://www.w3.org/2001/XMLSchema#string

Siv Jönsson

http://www.w3.org/2001/XMLSchema#string

P2860

The analgesic activity of morphine-6-glucuronide.

Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study

Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide

Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

Randomized placebo-controlled trial of the activity of the morphine glucuronides.

Clinical pharmacokinetics of morphine.

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children.

P2888

s40262-016-0471-7

P304

733-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40262-016-0471-7

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017921368

http://www.w3.org/2001/XMLSchema#string

P698

27815868

http://www.w3.org/2001/XMLSchema#string

P921

P932

5488155

http://www.w3.org/2001/XMLSchema#string